ChartMill · Sep 25, 2026
Curious about the stocks that are showing activity after the closing bell on Friday?
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
AD
NASDAQ · ADGM
Adagio Medical Holdings, Inc.
Healthcare · Medical - Devices
$0.09
Up+$0.00 (+0.00%)
Updated Nov 5, 2026, 5:42 AM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 15.22M
- P/E ratio
- -0.21
- Dividend yield
- 0.00%
- 52-week range
- $0.08 – $1.69
- Volume
- 155.85K
- Avg. volume
- 160.25K
Price performance · ADGM
ADGM price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 4, 2026
ADGM closed at $0.09 after 21 trading sessions, down 35.58% for the selected period.
- Last close
- $0.09
- Period change
- -35.58%
- Period low
- $0.08
- Period high
- $0.13
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 4, 2026 | $0.09 | $0.09 | $0.085 | $0.0862 | 155.85K |
| Nov 3, 2026 | $0.089 | $0.089 | $0.082 | $0.0862 | 155.48K |
| Nov 2, 2026 | $0.092 | $0.0927 | $0.0845 | $0.087 | 276.95K |
| Oct 30, 2026 | $0.091 | $0.0916 | $0.081 | $0.083 | 497.32K |
| Oct 29, 2026 | $0.1078 | $0.115 | $0.0832 | $0.086 | 1.18M |
| Oct 28, 2026 | $0.0936 | $0.1099 | $0.0898 | $0.1061 | 934.44K |
| Oct 27, 2026 | $0.0975 | $0.1083 | $0.0948 | $0.10 | 299.58K |
| Oct 26, 2026 | $0.10 | $0.1084 | $0.0921 | $0.0967 | 623.47K |
| Oct 23, 2026 | $0.108 | $0.11 | $0.1009 | $0.1026 | 712.62K |
| Oct 22, 2026 | $0.1118 | $0.1136 | $0.1047 | $0.1108 | 181.91K |
| Oct 21, 2026 | $0.118 | $0.1224 | $0.1076 | $0.1153 | 768.74K |
| Oct 20, 2026 | $0.1209 | $0.1227 | $0.115 | $0.1208 | 775.85K |
| Oct 19, 2026 | $0.101 | $0.1235 | $0.096 | $0.12 | 3.29M |
| Oct 16, 2026 | $0.1009 | $0.1063 | $0.095 | $0.099 | 626.07K |
| Oct 15, 2026 | $0.0877 | $0.106 | $0.0838 | $0.103 | 25.15M |
| Oct 14, 2026 | $0.1215 | $0.1255 | $0.083 | $0.089 | 3.21M |
| Oct 13, 2026 | $0.13 | $0.1359 | $0.1211 | $0.1253 | 793.85K |
| Oct 12, 2026 | $0.13 | $0.1418 | $0.1263 | $0.132 | 1.27M |
| Oct 9, 2026 | $0.1261 | $0.13 | $0.126 | $0.13 | 690.43K |
| Oct 8, 2026 | $0.1298 | $0.133 | $0.1201 | $0.13 | 1.49M |
| Oct 7, 2026 | $0.1353 | $0.14 | $0.125 | $0.1338 | 1.64M |
Latest ADGM news
The latest Smart Investors Daily articles mentioning ADGM.
Stock researchCompany · Overview
Company
Market Activity
Research & News
ADGM research
Overview
Company profile and research snapshot.
Company profile
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for the treatment of cardiac arrhythmias. The company focuses on developing cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 3, 2026 | LUCID CAPITAL MARKETS | Buy | — |
| Apr 14, 2026 | Piper Sandler | Overweight | — |
| Dec 2, 2025 | Lake Street | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Sep 25, 2026
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Onconetix (NASDAQ:ONCO) stock increased by 10.3% to $1.14 during Friday's after-market session. The market value of their outstanding shares is at $3.9 million. Bullfrog AI Hldgs (NASDAQ:BFRG) shares moved
Benzinga · Sep 23, 2026
Crude Oil Gains 1%; Cintas Earnings Top Views
U.S. stocks fell Wednesday, led by a 1.1% Nasdaq drop. Cintas beat estimates and raised guidance; oil gained while gold, silver and copper declined.
Yahoo · Sep 23, 2026
Adagio Medical Announces Strategic Review Process to Maximize Shareholder Value
LAGUNA HILLS, Calif., September 23, 2026--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that its Board of Directors has completed a comprehensive review of the Company's business, programs, resources and capabilities and has initiated a formal process to explore strategic alternatives focused on maximizing shareholder value. In connection with this decision,
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
